Quick Answer
Nuvalent, Inc. reported Net Income of -$425.38 million for fiscal year 2025.
Nuvalent, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net Income | -$425.38M -63.1% |
-$260.76M -106.6% |
-$126.22M -54.2% |
-$81.85M -76.6% |
-$46.34M -218.3% |
-$14.56M |
| Diluted EPS | -$5.85 -48.9% |
-$3.93 -81.1% |
-$2.17 -31.5% |
-$1.65 +22.5% |
-$2.13 +58.1% |
-$5.08 |
| Total Assets | $1.41B +23.7% |
$1.14B +55.9% |
$732.38M +51.8% |
$482.46M +64.2% |
$293.82M +2659.9% |
$10.65M |
| Cash and Equivalents | $261.75M +79.7% |
$145.69M -56.6% |
$335.39M +38.7% |
$241.81M +252.9% |
$68.53M +563.2% |
$10.33M +242.6% |
| Stockholders Equity | $1.25B +16.7% |
$1.07B +52.7% |
$700.56M +51.3% |
$462.98M +62.4% |
$285.04M +1010.0% |
-$31.32M -81.5% |
| R&D Expense | $306.97M +41.0% |
$217.77M +92.3% |
$113.24M +77.7% |
$63.73M +79.2% |
$35.56M +130.9% |
$15.40M |
| Operating Income | -$414.31M -47.8% |
-$280.37M -87.5% |
-$149.49M -73.6% |
-$86.11M -87.9% |
-$45.82M -171.0% |
-$16.91M |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | -$122.44M | -45.2% | -22.9% |
| Diluted EPS | September 30, 2025 | -$1.70 | -32.8% | -22.3% |
| Total Assets | September 30, 2025 | $979.91M | -17.6% | -5.8% |
| Cash and Equivalents | September 30, 2025 | $115.75M | -68.7% | -9.2% |
| Stockholders Equity | September 30, 2025 | $845.40M | -24.6% | -10.0% |
| R&D Expense | September 30, 2025 | $83.84M | +38.5% | +3.6% |
| Operating Income | September 30, 2025 | -$112.70M | -47.6% | -7.8% |
| Shares Outstanding | June 30, 2021 | 3.13M | — | +0.0% |
- Nuvalent, Inc. reported Net Income of -$425.38 million for fiscal year 2025.
- Nuvalent, Inc. showed a decrease of -63.1% in Net Income compared to the prior fiscal year.
- Nuvalent, Inc. reported Diluted EPS of $5.85 per share (loss) for fiscal year 2025.
- Nuvalent, Inc. showed a decrease of -48.9% in Diluted EPS compared to the prior fiscal year.
- Nuvalent, Inc. reported Total Assets of $1.41 billion for fiscal year 2025.
- Nuvalent, Inc. showed an increase of +23.7% in Total Assets compared to the prior fiscal year.
- Nuvalent, Inc. reported Cash and Equivalents of $261.75 million for fiscal year 2025.
- Nuvalent, Inc. showed an increase of +79.7% in Cash and Equivalents compared to the prior fiscal year.
- Nuvalent, Inc. reported Stockholders Equity of $1.25 billion for fiscal year 2025.
- Nuvalent, Inc. showed an increase of +16.7% in Stockholders Equity compared to the prior fiscal year.
- Nuvalent, Inc. reported R&D Expense of $306.97 million for fiscal year 2025.
- Nuvalent, Inc. showed an increase of +41.0% in R&D Expense compared to the prior fiscal year.
- Nuvalent, Inc. reported Operating Income of -$414.31 million for fiscal year 2025.
- Nuvalent, Inc. showed a decrease of -47.8% in Operating Income compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: